Bank of America’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.84M Buy
2,763,362
+505,951
+22% +$695K ﹤0.01% 3657
2025
Q4
$3.63M Buy
2,257,411
+468,911
+26% +$982K ﹤0.01% 3626
2025
Q3
$4.88M Buy
1,788,500
+678,020
+61% +$2.26M ﹤0.01% 4040
2025
Q2
$4.04M Buy
1,110,480
+628,570
+130% +$1.73M ﹤0.01% 4115
2025
Q1
$925K Sell
481,910
-62,006
-11% -$127K ﹤0.01% 5275
2024
Q4
$1.03M Buy
543,916
+294,343
+118% +$511K ﹤0.01% 4998
2024
Q3
$329K Buy
249,573
+22,429
+10% +$29.9K ﹤0.01% 5743
2024
Q2
$232K Sell
227,144
-128,312
-36% -$159K ﹤0.01% 5816
2024
Q1
$650K Buy
355,456
+132,637
+60% +$212K ﹤0.01% 5192
2023
Q4
$276K Sell
222,819
-1,259
-0.6% -$1.28K ﹤0.01% 5888
2023
Q3
$255K Buy
224,078
+121,550
+119% +$156K ﹤0.01% 5750
2023
Q2
$93.8K Sell
102,528
-90,931
-47% -$87.8K ﹤0.01% 6229
2023
Q1
$108K Buy
193,459
+59,695
+45% +$45.6K ﹤0.01% 6227
2022
Q4
$77.2K Sell
133,764
-147,942
-53% -$46.4K ﹤0.01% 6330
2022
Q3
$90K Sell
281,706
-183,382
-39% -$72K ﹤0.01% 6393
2022
Q2
$164K Buy
465,088
+60,835
+15% +$25.5K ﹤0.01% 6222
2022
Q1
$290K Sell
404,253
-54,826
-12% -$117K ﹤0.01% 6216
2021
Q4
$1.04M Buy
459,079
+300,669
+190% +$820K ﹤0.01% 5206
2021
Q3
$456K Buy
158,410
+71,863
+83% +$205K ﹤0.01% 5725
2021
Q2
$328K Sell
86,547
-178,660
-67% -$601K ﹤0.01% 5737
2021
Q1
$898K Buy
265,207
+191,125
+258% +$688K ﹤0.01% 4924
2020
Q4
$208K Sell
74,082
-35,574
-32% -$104K ﹤0.01% 5576
2020
Q3
$275K Sell
109,656
-37,771
-26% -$331K ﹤0.01% 5100
2020
Q2
$2M Sell
147,427
-57,917
-28% -$599K ﹤0.01% 3631
2020
Q1
$1.56M Buy
205,344
+52,900
+35% +$412K ﹤0.01% 3670
2019
Q4
$964K Sell
152,444
-32,819
-18% -$156K ﹤0.01% 4534
2019
Q3
$727K Sell
185,263
-183,116
-50% -$785K ﹤0.01% 4801
2019
Q2
$1.78M Buy
368,379
+85,513
+30% +$486K ﹤0.01% 4117
2019
Q1
$2.32M Buy
282,866
+142,752
+102% +$980K ﹤0.01% 3868
2018
Q4
$775K Sell
140,114
-2,823
-2% -$22.1K ﹤0.01% 4602
2018
Q3
$1.26M Sell
142,937
-173,612
-55% -$1.55M ﹤0.01% 4330
2018
Q2
$3.16M Buy
316,549
+55,790
+21% +$559K ﹤0.01% 3597
2018
Q1
$2.48M Buy
260,759
+68,167
+35% +$954K ﹤0.01% 3717
2017
Q4
$2.86M Sell
192,592
-116,938
-38% -$1.94M ﹤0.01% 3639
2017
Q3
$6.09M Buy
309,530
+15,672
+5% +$241K ﹤0.01% 2990
2017
Q2
$4.22M Sell
293,858
-107,300
-27% -$1.36M ﹤0.01% 3200
2017
Q1
$3.69M Sell
401,158
-86,391
-18% -$843K ﹤0.01% 3315
2016
Q4
$5.08M Sell
487,549
-18,225
-4% -$157K ﹤0.01% 2917
2016
Q3
$4.58M Sell
505,774
-38,889
-7% -$331K ﹤0.01% 2915
2016
Q2
$4.07M Sell
544,663
-546,218
-50% -$4.77M ﹤0.01% 2971
2016
Q1
$9.83M Buy
1,090,881
+413,880
+61% +$3.36M ﹤0.01% 2161
2015
Q4
$8.75M Buy
677,001
+348,330
+106% +$3.55M ﹤0.01% 2390
2015
Q3
$3.17M Buy
328,671
+227,318
+224% +$2.09M ﹤0.01% 3327
2015
Q2
$1.04M Buy
101,353
+82,334
+433% +$702K ﹤0.01% 4078
2015
Q1
$211K Sell
19,019
-4,010
-17% -$42.7K ﹤0.01% 4892
2014
Q4
$268K Buy
23,029
+21,448
+1,357% +$308K ﹤0.01% 5125
2014
Q3
$35K Buy
+1,581
New +$36.3K ﹤0.01% 6746

Other funds holding AKBA